Ryan Lindeman is an accomplished Executive Director in Clinical Development and Design at Eli Lilly and Company, specializing in neurodegeneration and gene therapy since 2023. Previously, they held the position of Senior Director for Clinical Research and Development, where they successfully accelerated the launch of crucial therapeutic molecules. With a robust background in chemical engineering and business administration, Ryan leverages their extensive experience to optimize clinical program strategies and lead cross-functional teams globally. Their expertise encompasses decentralized clinical trials and innovative drug development, making significant contributions to the pharmaceutical industry.
This person is not in any teams
This person is not in any offices